Next-Generation Imaging Articles

Next-Generation Imaging

PSMA Imaging in Oligometastatic Prostate Cancer

Zachary BessetteNext-Generation Imaging | January 31, 2023

Dr. Deek shares how PSMA imaging used in both the STOMP and ORIOLE trials.

RLT-PSMA in Development

Zachary BessetteNext-Generation Imaging | January 24, 2023

Dr. Ulaner highlights the line(s) of therapy in which novel RLT-PSMA agents are being developed.

Safety and Efficacy of 177Lu-PSMA-617

Zachary BessetteNext-Generation Imaging | January 24, 2023

Dr. Ulaner explains the data that led to the FDA approval of 177Lu-PSMA-617 and the safety profile of this drug.

Molecular Imaging and Therapy in Prostate Cancer

Zachary BessetteNext-Generation Imaging | January 24, 2023

Dr. Ulaner details the current application and capabilities of molecular imaging in prostate cancer.

Personalized Care and Next-Generation Sequencing: The Frontier of Advanced Prostate Cancer

Tomi Jun, MDExpert Interviews | January 5, 2023

Tomi Jun, MD, shares the clinical actionability and utilization of NGS for prostate cancer in a changing treatment landscape.

Presurgical PSMA-PET Tracers Provide Treatment Plan Benefit for Patients With Prostate Cancer

Zachary BessetteNext-Generation Imaging | December 22, 2022

The Ga-PSMA-11 and Ga-P16-093 PSMA-PET tracers are useful tools for surgical guidance in prostate cancer.

First AI Platform for Prostate Cancer Care Approved by FDA

Emily MenendezNext-Generation Imaging | December 8, 2022

iQuest is the first AI-powered platform of its kind to aid in the development of personalized prostate cancer care plans.

Usefulness of Collaborative Work in the Evaluation of Prostate Cancer from MRI

GU Oncology Now EditorsNext-Generation Imaging | June 1, 2022

...

Validation of an MRI-based prostate cancer prebiopsy Gleason score predictive nomogram

GU Oncology Now EditorsNext-Generation Imaging | May 31, 2022

...

Bridging the gap between prostate radiology and pathology through machine learning

GU Oncology Now EditorsNext-Generation Imaging | May 29, 2022

...

Fast Analysis of Time-Domain Fluorescence Lifetime Imaging via Extreme Learning Machine

GU Oncology Now EditorsNext-Generation Imaging | May 28, 2022

...

Integration of Deep Learning and Active Shape Models for More Accurate Prostate Segmentation in 3D MR Images

GU Oncology Now EditorsNext-Generation Imaging | May 27, 2022

...

Comparison between biparametric and multiparametric MRI diagnosis strategy for prostate cancer in the peripheral zone using PI-RADS version 2.1

GU Oncology Now EditorsNext-Generation Imaging | May 27, 2022

...

Domain adaptation of automated treatment planning from computed tomography to magnetic resonance

GU Oncology Now EditorsNext-Generation Imaging | May 25, 2022

...

A Combinatorial Neural Network Analysis Reveals a Synergistic Behaviour of Multiparametric Magnetic Resonance and Prostate Health Index in the Identification of Clinically Significant Prostate Cancer

GU Oncology Now EditorsNext-Generation Imaging | May 25, 2022

...

Impact of 18F-DCFPyL PET on Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate Cancer

GU Oncology Now EditorsNext-Generation Imaging | May 24, 2022

...

Cone-beam computed tomography-guided online adaptive radiotherapy is feasible for prostate cancer patients

GU Oncology Now EditorsNext-Generation Imaging | May 23, 2022

...

Management Impact of Metachronous Oligometastatic Disease Identified on 18F-Fluciclovine (Axumin™) PET/CT in Biochemically Recurrent Prostate Cancer

GU Oncology Now EditorsNext-Generation Imaging | May 23, 2022

...

PI-RADS: multiparametric MRI in prostate cancer

GU Oncology Now EditorsNext-Generation Imaging | May 21, 2022

...

Fibroblast Activation Protein-Specific MRI Enhances Tumor Mapping in Prostate Cancer

Vanessa IraAUA 2022 | May 16, 2022

This use of molecular MRI with targeted agents can enhance tumor margin detection and inform treatment decision-making.